Both in Pharmaceuticals
Palvella Therapeutics vs Aurinia Pharmaceuticals
Over the past year PVLA returned +99.0% and AUPH returned +25.7%; their daily moves had a correlation of 0.27.
PVLA +99.0% AUPH +25.7%Growth of $1, one year, split-adjusted
| Metric | PVLA | AUPH |
|---|---|---|
| Price | $152.93 | $16.56 |
| Market cap | $2.20B | $2.22B |
| Today | +4.51% | +2.60% |
| 1 month | +15.7% | +5.3% |
| 6 months | +18.1% | +3.2% |
| Year to date | +46.1% | +3.8% |
| 1 year | +91.5% | +25.7% |
| Revenue growth (YoY) | — | +13.9% |
| Gross margin | — | 90.1% |
| Net margin | — | 37.9% |
| P/E (TTM) | — | 7.1× |
| Price / sales | — | 6.9× |
| Net cash | $250.6M | $431.7M |
| Dividend yield | — | — |
| Volatility (60d) | 47.2% | 30.3% |
| Short % of float | 21.7% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).